Pharmacogenetics study of hydrochlorothiazide and felodipine in Chinese hypertensive patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-12002710

Enrollment

Unknown

Registered

2012-11-21

Start date

1995-01-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Hydrochlorothiazide:Hydrochlorothiazide

Hydrochlorothiazide+Felodipine:Hydrochlorothiazide+Felodipine

Eligibility

Sex/Gender

Male

Age

50 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with primary hypertension; (2) aged between 50 and 79.

Exclusion criteria

Exclusion criteria: Secondary hypertension; pregnant or lactating were excluded from this study

Design outcomes

Primary

Measure	Time frame
related gene;Blood pressure;	—

Countries

China

Contacts

Public ContactWei Zhang

yjsd2003@163.com+86 0731 84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026